Unlearn.ai introduces 'Digital Twins,' an AI-powered tool revolutionizing clinical research. This innovative technology assists in clinical trials across various medical fields, from neuroscience to immunology and metabolic diseases. Digital Twins create detailed models predicting a patient's future health by analyzing baseline data through AI models trained on historical data. This tool enhances early and late-stage studies, improving observation of treatment effects without increasing patient numbers and expediting trial enrollment. Additionally, it provides prognostic scores for patients in randomized clinical trials, aligning with FDA and EMA guidelines. Unlearn's Digital Twins offer personalized medicine applications, partner with pharma innovators, and enhance the efficiency and accuracy of clinical trials.